Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
23,977,302
-
Share change
-
-563,574
-
Total reported value
-
$21,483,764
-
Price per share
-
$0.90
-
Number of holders
-
28
-
Value change
-
-$589,402
-
Number of buys
-
10
-
Number of sells
-
14
Institutional Holders of ASLAN PHARMACEUTICALS LTD - ADS (ASLN) as of Q1 2022
As of 31 Mar 2022,
ASLAN PHARMACEUTICALS LTD - ADS (ASLN) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,977,302 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, RTW INVESTMENTS, LP, Vivo Capital, LLC, CITADEL ADVISORS LLC, MANGROVE PARTNERS, ORBIMED ADVISORS LLC, Temasek Holdings (Private) Ltd, MILLENNIUM MANAGEMENT LLC, Sio Capital Management, LLC, and SABBY MANAGEMENT, LLC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.